<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="15/05/2006" creator="Yo Shidahara" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10102791"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10102791</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Carbohydrate" id="A1">PGG-glucan</term>, a <term sem="Carbohydrate" id="T1" lex="soluble_beta-(1,3)-glucan">soluble beta-(1,3)-glucan</term>, enhances the <term sem="Other" id="T2" lex="oxidative_burst_response">oxidative burst response</term>, <term sem="Other" id="T3" lex="microbicidal_activity">microbicidal activity</term>, and activates an <term sem="Protein_molecule" id="T4" lex="NF-kappa_B-like_factor"><term sem="Protein_complex" id="T5" lex="NF-kappa_B">NF-kappa B</term>-like factor</term> in <term sem="Cell_natural" id="T6" lex="human_PMN">human PMN</term>: evidence for a <term sem="Protein_molecule" id="T7" lex="glycosphingolipid_beta-(1,3)-glucan_receptor"><term sem="Carbohydrate" id="T8" lex="glycosphingolipid_beta-(1,3)-glucan">glycosphingolipid beta-(1,3)-glucan</term> receptor</term>.</sentence>
<event assertion="exist" uncertainty="certain" id="E1">
<type class="Positive_regulation" />
<theme idref="T2" />
<cause idref="A1" />
<clue>PGG-glucan, a soluble beta-(1,3)-glucan, <clueType>enhances</clueType> the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor <clueLoc>in human PMN</clueLoc>: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E2">
<type class="Positive_regulation" />
<theme idref="T3" />
<cause idref="A1" />
<clue>PGG-glucan, a soluble beta-(1,3)-glucan, <clueType>enhances</clueType> the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor <clueLoc>in human PMN</clueLoc>: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E3">
<type class="Positive_regulation" />
<theme idref="T4" />
<cause idref="A1" />
<clue>PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and <clueType>activates</clueType> an NF-kappa B-like factor <clueLoc>in human PMN</clueLoc>: evidence for a glycosphingolipid beta-(1,3)-glucan receptor.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Carbohydrate" id="T9" lex="PGG-Glucan">PGG-Glucan</term>, a <term sem="Carbohydrate" id="T10" lex="soluble_beta-(1,6)-branched_beta-(1,3)-linked_glucose_homopolymer">soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer</term> derived from the <term sem="Cell_component" id="T11" lex="cell_wall">cell wall</term> of the <term sem="Unicellular_organism" id="T12" lex="yeast">yeast</term> <term sem="Unicellular_organism" id="T13" lex="Saccharomyces_cerevisiae">Saccharomyces cerevisiae</term>, is an <term sem="Carbohydrate" id="T14" lex="immunomodulator">immunomodulator</term> which enhances <term sem="Other" id="T15" lex="leukocyte_anti-infective_activity"><term sem="Cell_natural" id="A2">leukocyte</term> anti-infective activity</term> and enhances <cons sem="(AND Other Other)" id="C1" lex="(AND myeloid_progenitor_proliferation megakaryocyte_progenitor_proliferation)"><frag id="F1">myeloid</frag> and <frag id="F2">megakaryocyte</frag> <frag id="F3">progenitor</frag> <frag id="F4">proliferation</frag></cons>.</sentence>
<event assertion="exist" uncertainty="certain" id="E4">
<type class="Physiological_process" />
<theme idref="A2" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an immunomodulator which enhances leukocyte <clueType>anti-infective activity</clueType> and enhances myeloid and megakaryocyte progenitor proliferation.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E104">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="T9" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an <corefCause>immunomodulator</corefCause> which <clueType>enhances</clueType> leukocyte anti-infective activity and enhances myeloid and megakaryocyte progenitor proliferation.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E5">
<type class="Cellular_physiological_process" />
<theme idref1="F3" idref="F1" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an immunomodulator which enhances leukocyte anti-infective activity and enhances myeloid and megakaryocyte progenitor <clueType>proliferation</clueType>.</clue>
<comment>NER T16 mod</comment></event>
<event assertion="exist" uncertainty="certain" id="E105">
<type class="Cellular_physiological_process" />
<theme idref1="F3" idref="F2" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an immunomodulator which enhances leukocyte anti-infective activity and enhances myeloid and megakaryocyte progenitor <clueType>proliferation</clueType>.</clue>
<comment>NER T16 mod</comment></event>
<event assertion="exist" uncertainty="certain" id="E6">
<type class="Positive_regulation" />
<theme idref="E5" />
<cause idref="T9" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an immunomodulator <corefCause>which</corefCause> enhances leukocyte anti-infective activity and <clueType>enhances</clueType> myeloid and megakaryocyte progenitor proliferation.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E106">
<type class="Positive_regulation" />
<theme idref="E105" />
<cause idref="T9" />
<clue>PGG-Glucan, a soluble beta-(1,6)-branched beta-(1,3)-linked glucose homopolymer derived from the cell wall of the yeast Saccharomyces cerevisiae, is an immunomodulator <corefCause>which</corefCause> enhances leukocyte anti-infective activity and <clueType>enhances</clueType> myeloid and megakaryocyte progenitor proliferation.</clue>
</event>
<sentence id="S3"><term sem="Other" id="T16">Incubation</term> of <term sem="Tissue_natural" id="T17" lex="human_whole_blood">human whole blood</term> with <term sem="Carbohydrate" id="T18" lex="PGG-Glucan">PGG-Glucan</term> significantly enhanced the <term sem="Other" id="T19" lex="oxidative_burst_response">oxidative burst response</term> of <term sem="Cell_natural" id="T20" lex="subsequently_isolated_blood_leukocyte">subsequently isolated blood leukocytes</term> to both <term sem="Other" id="A4">soluble</term> and <term sem="Other" id="A5">particulate</term> <term sem="Other" id="A6">activators</term> in a <term sem="Other" id="T21" lex="dose-dependent_manner">dose-dependent manner</term>, and increased <term sem="Other" id="T22" lex="leukocyte_microbicidal_activity"><term sem="Cell_natural" id="A7">leukocyte</term> microbicidal activity</term>.</sentence>
<event assertion="exist" uncertainty="certain" id="E7">
<type class="Artificial_process" />
<theme idref="T17" />
<theme idref="T18" />
<clue><clueType>Incubation</clueType> <linkTheme>of</linkTheme> human whole blood <linkTheme>with</linkTheme> PGG-Glucan significantly enhanced the oxidative burst response of subsequently isolated blood leukocytes to both soluble and particulate activators in a dose-dependent manner, and increased leukocyte microbicidal activity.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E8">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref1="A6" idref="A4" />
<clue>Incubation of human whole blood with PGG-Glucan significantly enhanced the <clueType>oxidative burst response</clueType> <linkTheme>of</linkTheme> subsequently isolated blood leukocytes <linkCause>to</linkCause> both soluble and particulate activators in a dose-dependent manner, and increased leukocyte microbicidal activity.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E9">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref1="A6" idref="A5" />
<clue>Incubation of human whole blood with PGG-Glucan significantly enhanced the <clueType>oxidative burst response</clueType> <linkTheme>of</linkTheme> subsequently isolated blood leukocytes <linkCause>to</linkCause> both soluble and particulate activators in a dose-dependent manner, and increased leukocyte microbicidal activity.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E10">
<type class="Positive_regulation" />
<theme idref="E8" />
<cause idref="E7" />
<clue>Incubation of human whole blood with PGG-Glucan significantly <clueType>enhanced</clueType> the oxidative burst response of subsequently isolated blood leukocytes to both soluble and particulate activators in a dose-dependent manner, and increased leukocyte microbicidal activity.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E11">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="E7" />
<clue>Incubation of human whole blood with PGG-Glucan significantly enhanced the oxidative burst response of subsequently isolated blood leukocytes to both soluble and particulate activators in a dose-dependent manner, and <clueType>increased</clueType> leukocyte microbicidal activity.</clue>
</event>
<sentence id="S4">No evidence for <term sem="Other" id="T24" lex="inflammatory_cytokine_production"><term sem="Protein_family_or_group" id="T25" lex="cytokine">inflammatory cytokine</term> production</term> was obtained under these conditions.</sentence>
<event assertion="exist" uncertainty="certain" id="E12">
<type class="Gene_expression" />
<theme idref="T25" />
<clue>No evidence for inflammatory cytokine <clueType>production</clueType> was obtained under these conditions.</clue>
<comment>NER T25 mod</comment></event>
<event assertion="non-exist" uncertainty="certain" id="E13">
<type class="Positive_regulation" />
<theme idref="E12" />
<cause idref="E7" />
<clue>No evidence for inflammatory cytokine production was <clueType>obtained</clueType> <linkCause>under</linkCause> <corefTheme>these conditions</corefTheme>.</clue>
</event>
<sentence id="S5"><term sem="Other" id="T26" lex="electrophoretic_mobility_shift_assay">Electrophoretic mobility shift assays</term> demonstrated that <term sem="Carbohydrate" id="T27" lex="PGG-Glucan">PGG-Glucan</term> induced the activation of an <term sem="Protein_molecule" id="T28" lex="NF-kappaB-like_nuclear_transcription_factor"><term sem="Protein_complex" id="T29" lex="NF-kappaB">NF-kappaB</term>-like nuclear transcription factor</term> in purified <term sem="Cell_natural" id="T23">human neutrophils</term>.</sentence>
<event assertion="exist" uncertainty="certain" id="E14">
<type class="Positive_regulation" />
<theme idref="T28" />
<clue>Electrophoretic mobility shift assays demonstrated that PGG-Glucan induced the <clueType>activation</clueType> <linkTheme>of</linkTheme> an NF-kappaB-like nuclear transcription factor in purified human neutrophils.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E15">
<type class="Positive_regulation" />
<theme idref="E14" />
<cause idref="T27" />
<clue><clueExperiment>Electrophoretic mobility shift assays</clueExperiment> demonstrated that PGG-Glucan <clueType>induced</clueType> the activation of an NF-kappaB-like nuclear transcription factor <clueLoc>in purified human neutrophils</clueLoc>.</clue>
</event>
<sentence id="S6">The binding of <term sem="Carbohydrate" id="T31" lex="H-_PGG-Glucan">3H-PGG-Glucan</term> to <term sem="Cell_component" id="T33" lex="human_leukocyte_membrane">human leukocyte membranes</term> was specific, concentration-dependent, saturable, and high affinity (Kd approximately 6 nM).</sentence>
<event assertion="exist" uncertainty="certain" id="E16">
<type class="Cell_adhesion" />
<theme idref="T31" />
<theme idref="T33" />
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> 3H-PGG-Glucan <linkTheme>to</linkTheme> human leukocyte membranes was specific, concentration-dependent, saturable, and high affinity (Kd approximately 6 nM).</clue>
<comment>NER T31 mod</comment></event>
<sentence id="S7"><term sem="Protein_molecule" id="A8">A <term sem="Protein_family_or_group" id="T34" lex="monoclonal_antibody">monoclonal antibody</term> specific to the <term sem="Lipid" id="T35" lex="glycosphingolipid">glycosphingolipid</term> <term sem="Lipid" id="T36" lex="lactosylceramide">lactosylceramide</term></term> was able to inhibit activation of the <term sem="Protein_molecule" id="T37" lex="NF-kappaB-like_factor"><term sem="Protein_complex" id="T38" lex="NF-kappaB">NF-kappaB</term>-like factor</term> by <term sem="Carbohydrate" id="T39" lex="PGG-Glucan">PGG-Glucan</term>, and ligand binding data, including <term sem="Other" id="T40" lex="polysaccharide_specificity"><term sem="Carbohydrate" id="T41" lex="polysaccharide">polysaccharide</term> specificity</term>, suggested that the <term sem="Lipid" id="T42" lex="PGG-Glucan_binding_moiety"><term sem="Carbohydrate" id="T43" lex="PGG-Glucan">PGG-Glucan</term> binding moiety</term> was <term sem="Lipid" id="T44" lex="lactosylceramide">lactosylceramide</term>.</sentence>
<event assertion="exist" uncertainty="certain" id="E17">
<type class="Positive_regulation" />
<theme idref="T37" />
<cause idref="T39" />
<clue>A monoclonal antibody specific to the glycosphingolipid lactosylceramide was able to inhibit <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappaB-like factor <linkCause>by</linkCause> PGG-Glucan, and ligand binding data, including polysaccharide specificity, suggested that the PGG-Glucan binding moiety was lactosylceramide.</clue>
<comment>TPS A8</comment></event>
<event assertion="exist" uncertainty="certain" id="E18">
<type class="Negative_regulation" />
<theme idref="E17" />
<cause idref="A8" />
<clue>A monoclonal antibody specific to the glycosphingolipid lactosylceramide was able to <clueType>inhibit</clueType> activation of the NF-kappaB-like factor by PGG-Glucan, and ligand binding data, including polysaccharide specificity, suggested that the PGG-Glucan binding moiety was lactosylceramide.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E19">
<type class="Binding" />
<theme idref="T43" />
<theme idref="T44" />
<clue>A monoclonal antibody specific to the glycosphingolipid lactosylceramide was able to inhibit activation of the NF-kappaB-like factor by PGG-Glucan, and ligand binding data, including polysaccharide specificity, suggested that the PGG-Glucan <clueType>binding</clueType> moiety was lactosylceramide.</clue>
</event>
<sentence id="S8">These results indicate that <term sem="Carbohydrate" id="T45" lex="PGG-Glucan">PGG-Glucan</term> enhances <term sem="Other" id="T46" lex="neutrophil_anti-microbial_function"><term sem="Cell_natural" id="A9">neutrophil</term> anti-microbial functions</term> and that interaction between this <term sem="Carbohydrate" id="T47" lex="beta-glucan">beta-glucan</term> and <term sem="Cell_natural" id="T48" lex="human_neutrophil">human neutrophils</term> is mediated by the <term sem="Lipid" id="T49" lex="glycosphingolipid">glycosphingolipid</term> <term sem="Lipid" id="T50" lex="lactosylceramide">lactosylceramide</term> present at the <term sem="Cell_component" id="T51" lex="cell_surface">cell surface</term>.</sentence>
<event assertion="exist" uncertainty="certain" id="E20">
<type class="Positive_regulation" />
<theme idref="A9" />
<cause idref="T45" />
<clue>These results indicate that PGG-Glucan <clueType>enhances</clueType> neutrophil anti-microbial functions and that interaction between this beta-glucan and human neutrophils is mediated by the glycosphingolipid lactosylceramide present at the cell surface.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E21">
<type class="Cell_adhesion" />
<theme idref="T45" />
<theme idref="T48" />
<clue>These results indicate that PGG-Glucan enhances neutrophil anti-microbial functions and that <clueType>interaction</clueType> <linkTheme>between</linkTheme> <corefTheme>this beta-glucan</corefTheme> and human neutrophils is mediated by the glycosphingolipid lactosylceramide present at the cell surface.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E22">
<type class="Positive_regulation" />
<theme idref="E21" />
<cause idref="T50" />
<clue>These results indicate that PGG-Glucan enhances neutrophil anti-microbial functions and that interaction between this beta-glucan and human neutrophils is <clueType>mediated</clueType> <linkCause>by</linkCause> the glycosphingolipid lactosylceramide present at the cell surface.</clue>
</event>
<event assertion="exist" uncertainty="certain" id="E23">
<type class="Positive_regulation" />
<theme idref="E21" />
<cause idref="T49" />
<clue>These results indicate that PGG-Glucan enhances neutrophil anti-microbial functions and that interaction between this beta-glucan and human neutrophils is <clueType>mediated</clueType> <linkCause>by</linkCause> the glycosphingolipid lactosylceramide present at the cell surface.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
